|
1
|
Siegel RL, Millaer KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Bielle F: Building diagnoses with four
layers: WHO 2016 classification of CNS tumors. Rev Neurol (Paris).
172:253–255. 2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Boussiotis VA and Charest A:
Immunotherapies for malignant glioma. Oncogene. 37:1121–1141.
2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Van Meir EG, Hadjipanayis CG, Norden AD,
Shu HK, Wen PY and Olson JJ: Exciting new advances in
neuro-oncology: The avenue to a cure for malignant glioma. CA
Cancer J Clin. 60:166–193. 2010.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Stupp R, Taillibert S, Kanner A, Read W,
Steinberg D, Lhermitte B, Toms S, Idbaih A, Ahluwalia MS, Fink K,
et al: Effect of tumor-treating fields plus maintenance
temozolomide vs maintenance temozolomide alone on survival in
patients with glioblastoma: A randomized clinical trial. JAMA.
318:2306–2316. 2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Bhan A, Soleimani M and Mandal SS: Long
noncoding RNA and cancer: A new paradigm. Cancer Res. 77:3965–3981.
2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Wang JZ, Xu CL, Wu H and Shen SJ: LncRNA
SNHG12 promotes cell growth and inhibits cell apoptosis in
colorectal cancer cells. Braz J Med Biol Res.
50(e6079)2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Wang O, Yang F, Liu Y, Lv L, Ma R, Chen C,
Wang J, Tan Q, Cheng Y, Xia E, et al: C-MYC-induced upregulation of
lncRNA SNHG12 regulates cell proliferation, apoptosis and migration
in triple-negative breast cancer. Am J Transl Res. 9:533–545.
2017.PubMed/NCBI
|
|
9
|
Wang P, Chen D, Ma H and Li Y: LncRNA
SNHG12 contributes to multidrug resistance through activating the
MAPK/Slug pathway by sponging miR-181a in non-small cell lung
cancer. Oncotarget. 8:84086–84101. 2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Zhang H and Lu W: LncRNA SNHG12 regulates
gastric cancer progression by acting as a molecular sponge of
miR320. Mol Med Rep. 17:2743–2749. 2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Gordon MA, Babbs B, Cochrane DR, Bitler BG
and Richer JK: The long non-coding RNA MALAT1 promotes ovarian
cancer progression by regulating RBFOX2-mediated alternative
splicing. Mol Carcinog. 58:196–205. 2019.PubMed/NCBI View
Article : Google Scholar
|
|
12
|
Xu Y, Zhang X, Hu X, Zhou W, Zhang P,
Zhang J, Yang S and Liu Y: The effects of lncRNA MALAT1 on
proliferation, invasion and migration in colorectal cancer through
regulating SOX9. Mol Med. 24(52)2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Ye Y, Zhang F, Chen Q, Huang Z and Li M:
LncRNA MALAT1 modified progression of clear cell kidney carcinoma
(KIRC) by regulation of miR-194-5p/ACVR2B signaling. Mol Carcinog.
58:279–292. 2019.PubMed/NCBI View
Article : Google Scholar
|
|
14
|
Jia L, Tian Y, Chen Y and Zhang G: The
silencing of LncRNA-H19 decreases chemoresistance of human glioma
cells to temozolomide by suppressing epithelial-mesenchymal
transition via the Wnt/β-Catenin pathway. Onco Targets Therapy.
11:313–321. 2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Cheng Z, Li Z, Ma K, Li X, Tian N, Duan J,
Xiao X and Wang Y: Long non-coding RNA XIST promotes glioma
tumorigenicity and angiogenesis by acting as a molecular sponge of
miR-429. J Cancer. 8:4106–4116. 2017.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Zhang R, Jin H and Lou F: The long
non-coding RNA TP73-AS1 interacted with miR-142 to modulate brain
glioma growth through HMGB1/RAGE pathway. J Cell Biochem.
119:3007–3016. 2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Zhan Y, Liu Y, Wang C, Lin J, Chen M, Chen
X, Zhuang C, Liu L, Xu W, Zhou Q, et al: Increased expression of
SUMO1P3 predicts poor prognosis and promotes tumor growth and
metastasis in bladder cancer. Oncotarget. 7:16038–16048.
2016.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Liu J, Song Z, Feng C, Lu Y, Zhou Y, Lin Y
and Dong C: The long non-coding RNA SUMO1P3 facilitates breast
cancer progression by negatively regulating miR-320a. Am J Transl
Res. 9:5594–5602. 2017.PubMed/NCBI
|
|
19
|
Zhang LM, Wang P, Liu XM and Zhang YJ:
LncRNA SUMO1P3 drives colon cancer growth, metastasis and
angiogenesis. Am J Transl Res. 9:5461–5472. 2017.PubMed/NCBI
|
|
20
|
Louis DN, Perry A, Reifenberger G, von
Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD,
Kleihues P and Ellison DW: The 2016 World Health Organization
Classification of tumors of the central nervous system: A summary.
Acta Neuropathol. 131:803–820. 2016.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Deng D, Luo K, Liu H, Nie X, Xue L, Wang
R, Xu Y, Cui J, Shao N and Zhi F: p62 acts as an oncogene and is
targeted by miR-124-3p in glioma. Cancer Cell Int.
19(280)2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Deng D, Xue L, Shao N, Qu H, Wang Q, Wang
S, Xia X, Yang Y and Zhi F: miR-137 acts as a tumor suppressor in
astrocytoma by targeting RASGRF1. Tumour Biol. 37:3331–3340.
2016.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Chattopadhyay S, Chaklader M and Law S:
Aberrant Wnt signaling pathway in the hematopoietic stem/progenitor
compartment in experimental leukemic animal. J Cell Commun Signal.
13:39–52. 2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Sun Y, Zheng ZP, Li H, Zhang HQ and Ma FQ:
ANRIL is associated with the survival rate of patients with
colorectal cancer, and affects cell migration and invasion in
vitro. Mol Med Rep. 14:1714–1720. 2016.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Mei D, Song H, Wang K, Lou Y, Sun W, Liu
Z, Ding X and Guo J: Up-regulation of SUMO1 pseudogene 3 (SUMO1P3)
in gastric cancer and its clinical association. Med Oncol.
30(709)2013.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Ge X, Cui H, Zhou Y, Yin D, Feng Y, Xin Q,
Xu X, Liu W, Liu S and Zhang Q: miR-320a modulates cell growth and
chemosensitivity via regulating ADAM10 in gastric cancer. Mol Med
Rep. 16:9664–9670. 2017.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Zhao W, Sun Q, Yu Z, Mao S, Jin Y, Li J,
Jiang Z, Zhang Y, Chen M, Chen P, et al: MiR-320a-3p/ELF3 axis
regulates cell metastasis and invasion in non-small cell lung
cancer via PI3K/Akt pathway. Gene. 670:31–37. 2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Zhao H, Dong T, Zhou H, Wang L, Huang A,
Feng B, Quan Y, Jin R, Zhang W, Sun J, et al: miR-320a suppresses
colorectal cancer progression by targeting Rac1. Carcinogenesis.
35:886–895. 2014.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Hsieh IS, Chang KC, Tsai YT, Ke JY, Lu PJ,
Lee KH, Yeh SD, Hong TM and Chen YL: MicroRNA-320 suppresses the
stem cell-like characteristics of prostate cancer cells by
downregulating the Wnt/beta-catenin signaling pathway.
Carcinogenesis. 34:530–538. 2013.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Wu S, Chen S, Lin N and Yang J: Long
non-coding RNA SUMO1P3 promotes hepatocellular carcinoma
progression through activating Wnt/β-catenin signalling pathway by
targeting miR-320a. J Cell Mol Med. 24:3108–3116. 2020.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Fu M, Wang C, Li Z, Sakamaki T and Pestell
RG: Minireview: Cyclin D1: Normal and abnormal functions.
Endocrinology. 145:5439–5447. 2004.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Tam WL and Weinberg RA: The epigenetics of
epithelial-mesenchymal plasticity in cancer. Nat Med. 19:1438–1449.
2013.PubMed/NCBI View
Article : Google Scholar
|
|
34
|
Noh MG, Oh SJ, Ahn EJ, Kim YJ, Jung TY,
Jung S, Kim KK, Lee JH, Lee KH and Moon KS: Prognostic significance
of E-cadherin and N-cadherin expression in Gliomas. BMC cancer.
17(583)2017.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Lou JY, Luo J, Yang SC, Ding GF, Liao W,
Zhou RX, Qiu CZ and Chen JM: Long non-coding RNA SUMO1P3 promotes
glioma progression via the Wnt/β-catenin pathway. Eur Rev Med
Pharmacol Sci. 24:9571–9580. 2020.PubMed/NCBI View Article : Google Scholar
|
